Upper Cross Syndrome Rehabilitation Strengthening of the Dorsal Erector Muscles

Sponsor
Martín, Carlos García (Other)
Overall Status
Completed
CT.gov ID
NCT04540614
Collaborator
(none)
60
1
2
12.5
4.8

Study Details

Study Description

Brief Summary

The purpose of this study is to determine which treatment is more effective for chronic neck pain associated with Upper Cross Syndrome.

Condition or Disease Intervention/Treatment Phase
  • Other: Strengthening exercises programme
N/A

Detailed Description

Patients will divided in two groups, control and intervention. Control Group will do exercises of strengthening of Deep Cervical Flexors, Shoulder External Rotators and Adduction of Scapulae.

Intervention group will do the same plus Strengthtening of Erector Thoracic.

Study Design

Study Type:
Interventional
Actual Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Upper Cross Syndrome Rehabilitation by Means of Habitual Treatment Plus Strengthening of the Dorsal Erector Muscles. Controlled Clinical Trial.
Actual Study Start Date :
May 21, 2020
Actual Primary Completion Date :
May 3, 2021
Actual Study Completion Date :
Jun 4, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention

70 participants receiving active comparator treatment plus experimental

Other: Strengthening exercises programme
Strengthening exercises for Deep Cervical Flexors, Shoulder external rotators, scapular adductors and thoracic erector muscles

Active Comparator: Control

70 participants receiving active comparator treatment

Other: Strengthening exercises programme
Strengthening exercises for Deep Cervical Flexors, Shoulder external rotators, scapular adductors and thoracic erector muscles

Outcome Measures

Primary Outcome Measures

  1. Craniovertebral angle [0 week]

    tha angle formed by the horizontal line through C7 and the line formed between C7 and the tragus of the ear

  2. Craniovertebral angle [4 week]

    tha angle formed by the horizontal line through C7 and the line formed between C7 and the tragus of the ear

  3. Craniovertebral angle [8 week]

    tha angle formed by the horizontal line through C7 and the line formed between C7 and the tragus of the ear

  4. Shoulder angle [0 week]

    the angle formed by the horizontal line through C7 and the line formed between C7 and the acromion

  5. Shoulder angle [4 week]

    the angle formed by the horizontal line through C7 and the line formed between C7 and the acromion

  6. Shoulder angle [8 week]

    the angle formed by the horizontal line through C7 and the line formed between C7 and the acromion

  7. VAS [0 week]

    The Visual Analogue Scale 0 no pain 10 worst pain

  8. VAS [4 week]

    The Visual Analogue Scale 0 no pain 10 worst pain

  9. VAS [8 week]

    The Visual Analogue Scale 0 no pain 10 worst pain

Secondary Outcome Measures

  1. Muscle Strenght [0 week]

    Muscle strenght tested by a hand held dynamometer

  2. Muscle Strenght [4 week]

    Muscle Strenght tested by a hand held dynamometer

  3. Muscle Strenght [8 week]

    Muscle strenght tested by a and held dynamometer

  4. Muscle Activity [0 week]

    Muscle activity tested by Portable EMG

  5. Muscle Activity [4 week]

    Muscle activity tested by Portable EMG

  6. Muscle Activity [8 week]

    Muscle activity tested by Portable EMG

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Chronic neck pain for at least 3 months

  • 52º or less in the craniovertebral angle

  • 50º or less in the shoulder angle

Exclusion Criteria:
  • herniated disk, radiculopathy, diseases of the spine

Contacts and Locations

Locations

Site City State Country Postal Code
1 Fisiosesto Madrid Spain 28009

Sponsors and Collaborators

  • Martín, Carlos García

Investigators

  • Principal Investigator: Carlos García, Fisiosesto

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Martín, Carlos García
ClinicalTrials.gov Identifier:
NCT04540614
Other Study ID Numbers:
  • MartinCG
First Posted:
Sep 7, 2020
Last Update Posted:
Sep 14, 2021
Last Verified:
Feb 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Martín, Carlos García
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 14, 2021